Showing all 43 results
Amoxicillin & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, ultra-low moisture Alu-Alu blister strips (often containing integrated desiccants) to ensure the absolute stability of the incredibly hygroscopic Clavulanate salt.
Active Ingredient Strength Primary Clinical Function Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.500 mg
125 mg
(Total: 625 mg)Standard Adult Dose: Therapy for moderate RTIs, dental infections, and skin infections. Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.875 mg
125 mg
(Total: 1000 mg)High-Dose Adult Therapy: Aggressive intervention for severe pneumonia, severe sinus infections, and bite wounds. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Moisture Scavenger (Engineered for immediate gastric dissolution) *Pack Sizes: 1×6 or 1×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-7 day acute antibiotic regimens).
Cefadroxil 500 mg Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the beta-lactam ring.
Active Ingredient Strength Primary Clinical Function Cefadroxil Monohydrate USP/Ph.Eur. 500 mg (Equivalent to anhydrous Cefadroxil) Global Standard: Twice-daily adult therapy for pharyngitis, skin infections, and UTIs. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Macrogol / Magnesium Stearate Diluent / Superdisintegrant / Film-Coating (Engineered for rapid gastric dissolution and high bioavailability) Cefadroxil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Cefadroxil (as Monohydrate) USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections in adolescents. Cefadroxil (as Monohydrate) USP/Ph.Eur. 500 mg The Dermatology & UTI Payload: High-efficacy therapeutic dose for Cellulitis, Impetigo, and bladder infections. Excipients Proprietary Matrix High-Density Granulation: Engineered to manage the bulk of the 500mg payload while ensuring rapid disintegration and consistent absorption. Cefdinir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Cefdinir USP/Ph.Eur. 300 mg The Respiratory & Skin Anchor: The definitive therapeutic unit utilized for CAP, Sinusitis, and Skin/Soft Tissue Infections (SSTI). Excipients Proprietary Matrix Crystalline Form Stability: Engineered utilizing specialized binders to maintain the Crystalline Form I of Cefdinir, ensuring maximum shelf-life and predictable intestinal absorption. Cefixime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Clavulanic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Linezolid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive APIs.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Gram-Negative Anchor: Broad-spectrum bactericidal activity against H. influenzae, E. coli, and Salmonella. Linezolid USP/Ph.Eur. 600 mg The Gram-Positive Powerhouse: Bacteriostatic activity against multi-drug resistant Staphylococci and Streptococci. Excipients Proprietary Matrix Advanced Disintegration System: Engineered utilizing Super-Disintegrants to manage the large 800mg+ active payload, ensuring the tablet shatters rapidly for maximum absorption. Cefixime and Ofloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Extracellular Specialist: Targets the bacterial cell wall; highly effective against Gram-negative enteric pathogens. Ofloxacin USP/Ph.Eur. 200 mg The Intracellular Specialist: Targets DNA replication; excellent tissue penetration into the lungs, prostate, and urinary tract. Excipients Proprietary Matrix Bilayer Technology: Engineered to prevent physical interaction between the two APIs, ensuring maximum stability and a synchronized release profile in the gut. Cefixime Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime Trihydrate USP/Ph.Eur. 100 mg / 200 mg The Pediatric & Enteric Anchor: Dispersible format for easy administration in children and patients with dysphagia. Excipients Sweetening & Flavoring Agents Compliance Engineering: Formulated with high-grade fruit flavors and non-cariogenic sweeteners to mask the bitter antibiotic taste, ensuring 100% pediatric compliance. Disintegrants Super-Disintegrant Blend Instant-Dispersible Matrix: Engineered to shatter and form a smooth, grit-free suspension in < 45 seconds when placed in 5-10 mL of water. Cefixime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the trihydrate salt.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Standard Primary Care Anchor: Utilized for uncomplicated UTIs, Otitis Media, and Pharyngitis. Cefixime (as Trihydrate) USP/Ph.Eur. 400 mg The Enteric & Gonorrhea Payload: High-efficacy therapeutic dose for Typhoid Fever and uncomplicated Gonorrhea. Excipients Proprietary Matrix Solubility Enhancement: Engineered utilizing Laser Micronization of the API to ensure rapid dissolution and 100% bioequivalence to the innovator brand. Cefopodoxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 100 mg The Pediatric & Titration Anchor: Ideal for Pharyngitis, Tonsillitis, and uncomplicated UTIs in adolescents and adults. Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The Respiratory Macrodose: High-efficacy payload for Community-Acquired Pneumonia and Sinusitis. Excipients Proprietary Matrix Solubility Enhancement: Engineered utilizing micronized API and specialized surfactants to overcome the naturally poor solubility of the Proxetil salt. Cefpodoxime & Clavulanic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefpodoxime Proxetil Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 50 mg / 100 mg The Pediatric & Titration Anchor: Dispersible format for easy administration in children and elderly patients with swallowing difficulties. Excipients Sweetening & Flavoring Agents Bitter-Shield Technology: Engineered with molecular masking agents (e.g., Cyclodextrins) to neutralize the intense bitterness of the API, ensuring 100% pediatric compliance. Disintegrants Croscarmellose Sodium / SSG Instant-Dispersible Matrix: Engineered to shatter and form a uniform suspension in < 60 seconds when placed in 5-10 mL of water. Cefpodoxime-Potassium-Clavulanate-Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefprozil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-Alu blister strips to prevent hydrolytic degradation.
Active Ingredient Strength Primary Clinical Function Cefprozil USP/Ph.Eur. 250 mg The Pediatric & Mild Infection Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections. Cefprozil USP/Ph.Eur. 500 mg The Respiratory & SSTI Macrodose: Utilized for Acute Sinusitis, secondary infections of Bronchitis, and complicated skin infections. Excipients Proprietary Matrix Hydrolysis-Resistant Formulation: Engineered utilizing high-density granulation to protect the monohydrate API from environmental moisture. Cefuroxime Axetil Tablets
FreeProduct Composition & StrengthWe supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Utilized for Acute Otitis Media, Pharyngitis, and uncomplicated UTIs. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: Utilized for Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Proprietary Matrix Amorphous Solid Dispersion Technology: Engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates. Cefuroxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips to ensure the stability of the hygroscopic prodrug.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur.
(Equivalent to Cefuroxime)250 mg The Pediatric & ENT Anchor: The definitive unit utilized for the treatment of Acute Otitis Media, Pharyngitis, and uncomplicated Urinary Tract Infections. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: The high-efficacy therapeutic payload required for the management of Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Colloidal Silicon Dioxide / Premium Polymeric Film Diluent / Superdisintegrant / Solubilizer / Glidant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion Technology. Because crystalline Cefuroxime Axetil has near-zero bioavailability, our tablets are engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates). *Pack Sizes: 1×6, 1×10, or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-10 day acute curative regimens).
Minocycline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or opaque HDPE bottles to ensure the absolute chemical stability of the photosensitive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Minocycline (as Hydrochloride) USP/Ph.Eur. 50 mg (ER) Dermatology Maintenance Standard: Long-term, low-dose therapy for controlling inflammatory acne and severe Rosacea with minimal side effects. Minocycline (as Hydrochloride) USP/Ph.Eur. 100 mg (ER) Acute Clearance Standard: High-dose therapy for severe cystic acne breakouts, CA-MRSA skin infections, and Rheumatoid Arthritis flares. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate / Premium Opaque Opadry Film Hydrophilic ER Polymer / Diluent / Lubricant / UV-Blocking Coating (Engineered specifically to pace the gastric release over several hours, preventing the rapid blood-brain-barrier saturation that triggers vertigo) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 12-to-16 week chronic dermatology dispensing regimens).
Moxifloxacin & Cefixime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive antibiotic compounds.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg 4th-Gen Fluoroquinolone: Deep tissue and lung penetration to eradicate DNA replication in resistant respiratory and intra-abdominal pathogens. Cefixime (as Trihydrate) Ph.Eur./USP 400 mg 3rd-Gen Cephalosporin: Massive Gram-negative cell wall destruction, specifically targeting enteric pathogens like Salmonella typhi. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the hygroscopic Cefixime Trihydrate and mask the intensely bitter taste of Moxifloxacin) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 7-to-14 day acute critical-care anti-infective dispensing regimens).
Moxifloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg Global Pulmonology Standard: High-dose adult therapy for the aggressive eradication of resistant respiratory, skin, and intra-abdominal pathogens. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the highly hygroscopic API and completely mask its intensely bitter taste) *Pack Sizes: 1×5 or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-14 day acute critical-care dispensing regimens).
Nitrofurantoin Tablets
FreeA Nitrofurantoin tablet is an antibiotic specifically used to treat and prevent urinary tract infections (UTIs), such as cystitis. It works by damaging the DNA of bacteria in the urinary tract.
Nitrofurantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.
Active Ingredient Strength Primary Clinical Function Nitrofurantoin (Macrocrystals) USP/Ph.Eur. 50 mg Prophylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing. Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP 100 mg Global Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis. Excipients Carbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).
Norfloxacin & Tinidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Norfloxacin USP/Ph.Eur. 400 mg Aerobic Gut/UTI Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Tinidazole USP/Ph.Eur. 600 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and pelvic anaerobes. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 5-to-10 day acute anti-infective dispensing regimens).
Ofloxacin & Ornidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Ofloxacin USP/Ph.Eur. 200 mg Aerobic Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Ornidazole INN/Ph.Eur. 500 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and surgical-site anaerobes. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-5 day acute anti-infective dispensing regimens).
Ofloxacin & Satranidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the fluoroquinolone and nitroimidazole APIs.
Active Ingredient Strength Primary Clinical Function Ofloxacin USP/Ph.Eur. 200 mg Broad-spectrum fluoroquinolone for the eradication of aerobic bacterial pathogens. Satranidazole INN/Ph.Eur. 300 mg Premium nitroimidazole for the eradication of anaerobic bacteria and protozoa. Excipients Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Hypromellose Diluent / Superdisintegrant / Lubricant / Premium Film-Coating (Engineered to mask bitterness and ensure immediate gastric dissolution) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for standard 3-to-5 day acute gastrointestinal and pelvic infection regimens).
Ornidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredient.
Active Ingredient Strength Primary Clinical Function Ornidazole INN/Ph.Eur. 500 mg Global Clinical Standard: Base therapeutic unit for the rapid eradication of protozoal and anaerobic pathogens. Excipients Microcrystalline Cellulose / Maize Starch / Sodium Starch Glycolate / Hypromellose / Titanium Dioxide Diluent / Binder / Superdisintegrant / Premium Film-Coating (Engineered specifically to create an impenetrable barrier that completely masks the notoriously bitter, foul taste of the nitroimidazole API, ensuring flawless patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-10 day acute anti-infective dispensing regimens).
Prulifloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the ester prodrug.
Active Ingredient Strength Primary Clinical Function Prulifloxacin INN/Ph.Eur. 600 mg Global Clinical Standard: Maximum adult daily dose for the rapid eradication of susceptible UTI and RTI pathogens. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate / Hypromellose Diluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered for immediate gastric dissolution and synchronized prodrug absorption) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for standard 3-to-10 day acute urology and respiratory infection dispensing regimens).
